An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
Clinical trial NCT04201262 · COMPLETED
Trial details
- NCT number
- NCT04201262
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-09
- Primary completion
- 2022-03-15
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.